|
Name |
Naphthalene, 1,2,3,4-tetrahydro-5-methyl-
|
Molecular Formula | C11H14 | |
IUPAC Name* |
5-methyl-1,2,3,4-tetrahydronaphthalene
|
|
SMILES |
CC1=C2CCCCC2=CC=C1
|
|
InChI |
InChI=1S/C11H14/c1-9-5-4-7-10-6-2-3-8-11(9)10/h4-5,7H,2-3,6,8H2,1H3
|
|
InChIKey |
YXOVIGZJPGLNGM-UHFFFAOYSA-N
|
|
Synonyms |
2809-64-5; 5-METHYLTETRALINE; 5-Methyl-1,2,3,4-tetrahydronaphthalene; Naphthalene, 1,2,3,4-tetrahydro-5-methyl-; 5-METHYLTETRALIN; 888WK5BNU1; 1-Methyl-5,6,7,8-tetrahydronaphthalene; 1,2,3,4-Tetrahydro-5-methyl-naphthalene; UNII-888WK5BNU1; DTXSID50182365; MFCD00216193; ZINC95891302; AKOS006273345; 1,2,3,4-tetrahydro-5-methylnaphthalene; AS-56833; CS-0197111; FT-0705885; N10858; Q27269900
|
|
CAS | 2809-64-5 | |
PubChem CID | 17768 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 146.23 | ALogp: | 3.7 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 0.0 | Aromatic Rings: | 2 |
Heavy Atoms: | 11 | QED Weighted: | 0.524 |
Caco-2 Permeability: | -4.467 | MDCK Permeability: | 0.00001880 |
Pgp-inhibitor: | 0.045 | Pgp-substrate: | 0.002 |
Human Intestinal Absorption (HIA): | 0.002 | 20% Bioavailability (F20%): | 0.167 |
30% Bioavailability (F30%): | 0.963 |
Blood-Brain-Barrier Penetration (BBB): | 0.922 | Plasma Protein Binding (PPB): | 94.39% |
Volume Distribution (VD): | 1.951 | Fu: | 4.60% |
CYP1A2-inhibitor: | 0.954 | CYP1A2-substrate: | 0.886 |
CYP2C19-inhibitor: | 0.713 | CYP2C19-substrate: | 0.241 |
CYP2C9-inhibitor: | 0.291 | CYP2C9-substrate: | 0.85 |
CYP2D6-inhibitor: | 0.36 | CYP2D6-substrate: | 0.917 |
CYP3A4-inhibitor: | 0.121 | CYP3A4-substrate: | 0.233 |
Clearance (CL): | 7.724 | Half-life (T1/2): | 0.343 |
hERG Blockers: | 0.034 | Human Hepatotoxicity (H-HT): | 0.056 |
Drug-inuced Liver Injury (DILI): | 0.045 | AMES Toxicity: | 0.074 |
Rat Oral Acute Toxicity: | 0.055 | Maximum Recommended Daily Dose: | 0.131 |
Skin Sensitization: | 0.675 | Carcinogencity: | 0.298 |
Eye Corrosion: | 0.879 | Eye Irritation: | 0.992 |
Respiratory Toxicity: | 0.211 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000345 | 0.405 | D0E6YQ | 0.382 | ||||
ENC000364 | 0.333 | D0WO8W | 0.323 | ||||
ENC006050 | 0.333 | D0G4YT | 0.307 | ||||
ENC001334 | 0.311 | D0UM7O | 0.305 | ||||
ENC000907 | 0.308 | D05IHU | 0.305 | ||||
ENC000038 | 0.306 | D09RHQ | 0.294 | ||||
ENC001380 | 0.300 | D0H7AV | 0.290 | ||||
ENC000390 | 0.298 | D0N8DP | 0.288 | ||||
ENC000179 | 0.286 | D09QUQ | 0.282 | ||||
ENC000028 | 0.286 | D0A0FL | 0.282 |